180 related articles for article (PubMed ID: 35215237)
1. Combined Administration of (
Rafało-Ulińska A; Brański P; Pałucha-Poniewiera A
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215237
[TBL] [Abstract][Full Text] [Related]
2. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
[TBL] [Abstract][Full Text] [Related]
3. The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of (
Pałucha-Poniewiera A; Bobula B; Rafało-Ulińska A
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37083635
[TBL] [Abstract][Full Text] [Related]
4. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
5. Partial mGlu
Pałucha-Poniewiera A; Rafało-Ulińska A; Santocki M; Babii Y; Kaczorowska K
Pharmacol Rep; 2024 Jun; 76(3):504-518. PubMed ID: 38632187
[TBL] [Abstract][Full Text] [Related]
6. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
7. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
Pałucha-Poniewiera A; Podkowa K; Pilc A
Behav Pharmacol; 2019 Sep; 30(6):471-477. PubMed ID: 30724804
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice.
Rafało-Ulińska A; Pałucha-Poniewiera A
Behav Brain Res; 2022 Feb; 418():113633. PubMed ID: 34673124
[TBL] [Abstract][Full Text] [Related]
9. The role of mGlu
Pałucha-Poniewiera A
Pharmacol Biochem Behav; 2022 Oct; 220():173454. PubMed ID: 36038006
[TBL] [Abstract][Full Text] [Related]
10. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
11. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
12. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
Podkowa K; Pochwat B; Brański P; Pilc A; Pałucha-Poniewiera A
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960
[TBL] [Abstract][Full Text] [Related]
13. Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model.
Sun HL; Zhou ZQ; Zhang GF; Yang C; Wang XM; Shen JC; Hashimoto K; Yang JJ
Transl Psychiatry; 2016 Feb; 6(2):e741. PubMed ID: 26905413
[TBL] [Abstract][Full Text] [Related]
14. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
Fukumoto K; Iijima M; Chaki S
Neuropsychopharmacology; 2016 Mar; 41(4):1046-56. PubMed ID: 26245499
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Fukumoto K; Iijima M; Chaki S
Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
[TBL] [Abstract][Full Text] [Related]
16. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Koike H; Iijima M; Chaki S
Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
Podkowa K; Podkowa A; Sałat K; Lenda T; Pilc A; Pałucha-Poniewiera A
Neuropharmacology; 2016 Dec; 111():169-179. PubMed ID: 27569995
[TBL] [Abstract][Full Text] [Related]
19. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
20. Effects of Chronic LY341495 on Hippocampal mTORC1 Signaling in Mice with Chronic Unpredictable Stress-Induced Depression.
Seo MK; Lee JA; Jeong S; Seog DH; Lee JG; Park SW
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
